Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for QuantRX Biomedical Corp. (QTXB : OTC)
 
 • Company Description   
A-Fem Medical Corporation is a development stage medical technologycompany with multiple product platforms targeting women's health needs.

Number of Employees: 2

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.01 Daily Weekly Monthly
20 Day Moving Average: 4,697 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 0.18
52 Week High: $0.02
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -22.50% -12.72%
12 Week -8.82% 0.23%
Year To Date -38.00% -24.25%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10190 SW 90TH AVENUE
-
TUALATIN,OR 97062
USA
ph: 212-980-2235
fax: 1-267-880-1596
None http://www.quantrx.com
 
 • General Corporate Information   
Officers
Shalom Hirschman - Chief Executive Officer; Principal Accounting Offi
Michael Abrams - Director
Shalom Hirschman - Director
Michael Abrams - Director
Shalom Hirschman - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 74765N109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 05/23/22
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 6.00 (0.10:1)
Beta: 0.18
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/23/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -1,704.00
12/31/21 - -1,007.23
09/30/21 - -688.80
Current Ratio
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.01
Quick Ratio
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.01
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©